Stockreport

Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder [Yahoo! Finance]

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Addex Therapeutics and Indivior PLC (NASDAQ: INDV ) announced that they have selected clinical candidates from their GABAB-positive allosteric modulator (PAM) research [Read more]